Advertisement
Eskew, who served as chairman and chief executive officer of UPS fromJanuary, 2002 until December, 2007, brings over 35 years of global corporatemanagement experience to the Lilly board.
Advertisement
"We are very pleased to welcome Mike Eskew to the Lilly board," saidSidney Taurel, Lilly chairman and chief executive officer. "His extensivemanagement experiences and his outstanding track record of leadership in acustomer-centered organization such as UPS ideally suit him to provideguidance and oversight to Lilly as it transforms itself into a truly patient-centered enterprise. Mike's experience as a board member of other leadingAmerican companies will also serve our company well."
Eskew, 58, began his UPS career in 1972 as an industrial engineeringmanager. After several global assignments with increasing responsibility, hewas named corporate vice president for industrial engineering in 1993. In 1996he became group vice president for engineering, and in 1998, he was elected tothe UPS Board of Directors. In 1999, Eskew was named executive vice presidentand a year later was given the additional title of vice chairman. Eskewserves as a trustee of The UPS Foundation and as the chairman of the Board ofTrustees of The Annie E. Casey Foundation. He also serves on the boards ofdirectors of UPS, the 3M Corporation and IBM.
Lilly also announced that George M.C. Fisher, 67, will retire from thecompany's board of directors at the expiration of his current term, which endson April 21, 2008. Fisher, the former chairman of the board and chiefexecutive officer of both Motorola, Inc. and Eastman Kodak Company, has servedon the Lilly board since 2000. Fisher is currently a senior advisor forKohlberg Kravis Roberts & Company, is the presiding director of General MotorsCorporation, and is a director of Visant Corporation.
"George has been an invaluable source of guidance and leadership duringhis time on the Lilly board, and he has served our company and itsshareholders extraordinarily well during a very challenging period. Both thecompany and I personally have benefited from his insights, and we thank himfor his service to Lilly and wish him well," said Taurel.
Lilly, a leading innovation-driven corporation, is developing a growingportfolio of first-in-class and best-in-class pharmaceutical products byapplying the latest research from its own worldwide laboratories and fromcollaborations with eminent scientific organizations. Headquartered inIndianapolis, Ind., Lilly provides answers - through medicines and information- for some of the world's most urgent medical needs. Additional informationabout Lilly is available at www.lilly.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )
C-LLY
SOURCE Eli Lilly and Company
